Flibanserin

Flibanserin is a medication approved for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. It is marketed under the brand name Addyi. Flibanserin is believed to work by affecting neurotransmitters in the brain, specifically serotonin and dopamine. It is taken orally once daily. The effectiveness of flibanserin has been demonstrated in clinical trials, with women reporting an increase in satisfying sexual events. However, it is important to note that flibanserin is not a libido enhancer for everyone and may not be effective for all individuals.

Common side effects associated with flibanserin include dizziness, nausea, fatigue, and sleepiness. Alcohol consumption should be avoided while taking flibanserin due to an increased risk of severe hypotension and syncope. It is also contraindicated in individuals with a history of certain liver problems and in those taking certain antifungal medications. The prescribing information for flibanserin outlines specific interactions and precautions that healthcare providers must consider before prescribing the medication. Flibanserin is a prescription-only medication and should be used under the guidance of a qualified healthcare professional.